Drug Metabolism and Pharmacokinetics

作者在投稿时必须声明在稿件准备过程中使用生成式人工智能工具的情况。 模型中文摘要

Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…

为提高透明度，本刊要求通讯作者使用CRediT分类中的相关角色提供每位共同作者对稿件的具体贡献。 模型中文摘要

For transparency, we require corresponding authors to provide co-author contributions to the manuscript using the relevant CRediT roles. The CRediT taxonomy includes 14 different roles describing each contributor's specific contribution to the scholarly output. The roles are: Conceptualization; Data curation; Formal analysis; Funding acquisition; Investigation; Methodology; Project administration;…

所有作者必须披露任何可能不当影响其工作的财务或个人关系，并需在两处（标题页文件或稿件文件中的摘要声明，以及单独的利益声明表）进行披露。 模型中文摘要

All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors must disclose any interests in two places:…

本刊提供开放获取和订阅两种出版选择：开放获取文章对订户和公众免费开放并允许复用，但作者或其资助方需支付开放获取出版费；订阅文章仅向订户等提供，无需支付开放获取出版费。 模型中文摘要

Please visit our Open Access page for more information about open access publishing in this journal.This journal offers authors a choice in publishing their research:Open Access• Articles are freely available to both subscribers and the wider public with permitted reuse• An Open Access publication fee is payable by authors or their research funderSubscription• Articles are made available to subscr…

本刊实行单盲同行评审，稿件经编辑初评后通常送至少两名独立专家评审，编辑对录用与否拥有最终决定权。 模型中文摘要

This journal operates a single anonymized review process. All contributions will be initially assessed by the editor for suitability for the journal. Papers deemed suitable are then typically sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor'…

所有投稿在编辑处理前将使用iThenticate/Crosscheck软件进行查重评估，未能通过预筛的稿件将被直接拒稿且不向作者提供查重结果，作者抄袭行为将上报其所属机构和资助方。 模型中文摘要

All DMPK submissions will be subjected to plagiarism evaluation using the software of iThenticate/Crosscheck prior to editorial processing. Manuscripts that cannot pass the plagiarism evaluation pre-screening will be automatically rejected without review and the plagiarism evaluation will not be provided to authors. For more information, please go to: https://www.elsevier.com/editors/perk/plagiari…

预印本可随时在任何地方共享，在预印本服务器上分享预印本不会被视为先行发表。 模型中文摘要

Please note that preprints can be shared anywhere at any time, in line with Elsevier's sharing policy. Sharing your preprints e.g. on a preprint server will not count as prior publication (see 'Multiple, redundant or concurrent publication' for more information).